LBRX Latest Press Releases

-- September 3, 2026 --

LB Pharmaceuticals to Participate in Upcoming September Investor Events Globe Newswire 4:05 PM

LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer Globe Newswire 8:00 AM

-- August 11, 2026 --

LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM

-- July 29, 2026 --

LB Pharmaceuticals Announces $150 Million Private Placement Globe Newswire 8:00 AM

-- July 22, 2026 --

LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia Globe Newswire 8:00 AM

-- July 10, 2026 --

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:38 PM

-- June 30, 2026 --

LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations Globe Newswire 8:00 AM

-- May 28, 2026 --

LB Pharmaceuticals to Participate in Upcoming June Investor Events Globe Newswire 4:05 PM

-- May 12, 2026 --

LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- April 22, 2026 --

LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software